News

  • Neurokinex rehab space dedicated to help children with paralysis opens in Almondsbury

    Neurokinex Charitable Trust, the UK’s leading provider of activity-based rehabilitation for people living with paralysis, has opened a dedicated children’s space at its Bristol site. The purpose-built space is designed to transform rehabilitation for children with spinal cord injuries, neurological conditions and other causes of paralysis. The expansion has been made possible thanks to the [...]

  • Blood test may spot Alzheimer’s earlier

    A blood test that tracks protein shape could help detect Alzheimer's earlier, research suggests, by spotting disease-linked changes missed by current methods. Current tests usually measure levels of two proteins, amyloid beta and phosphorylated tau, in the blood or spinal fluid, but these markers may not fully capture earlier biological changes linked to disease progression. [...]

  • Interview: Why we must never lose sight of the bigger picture as neuro OTs

    NR Times catches up with Victoria Holness-Waud, specialist neurological occupational therapist and founder and clinical director of 360 Rehab, to find out more about her approach and the current climate for occupational therapy in neuro-rehabilitation. The many roles we play in life, says Victoria Holness-Waud, are central to our identity. When those roles are threatened [...]

  • MS risk shared across ancestries

    People from South Asian, African and European backgrounds share many of the same genetic risk factors for MS, a UK study has found. MS affects around 150,000 people in the UK and more than 2m worldwide, yet most genetic research so far has focused on people of white European ancestry. The new study, one of [...]

  • Brain Prize honours touch and pain research

    Two scientists have won the Brain Prize for discoveries showing how the nervous system detects and processes touch and pain. David Ginty and Patrik Ernfors will share the Brain Prize 2026 for work that, according to the prize committee, has changed scientific understanding of how nerve cells in the skin turn painful, thermal and mechanical [...]

  • Recreational drugs more than double stroke risk, research suggests

    Recreational drugs can more than double stroke risk, with a major review suggesting some of the most concerning impacts are among younger people. Scientists analysed medical data from more than 100 million people and found stroke risk was 122 per cent higher for amphetamine users and 96 per cent higher for cocaine users than for [...]

  • Experts warn of potential link between microplastics and Parkinson’s

    Microplastics may disrupt brain processes linked to Parkinson's, with a review suggesting pollution could play a part in rising cases. Cases of Parkinson's have doubled over the past 25 years, and researchers said rising levels of plastic pollution in the environment may be partly responsible. The review drew on more than 100 earlier studies, including [...]

  • Wearable sensors may identify MS patients at risk of worsening disability

    Wearable devices may help identify multiple sclerosis patients at greater risk of worsening disability and loss of brain volume, a study suggests. Researchers found people whose activity patterns changed were more likely to have worsening disability and loss of brain volume than those whose patterns changed less or not at all. The study shows an [...]

  • Air pollution from wildfires linked to higher stroke rate

    Short-term spikes in wildfire smoke during the 2023 Canadian wildfires were linked to higher stroke rates and more severe strokes in New Jersey, a preliminary study suggests. Researchers used a stroke registry to identify strokes recorded in June and July 2023 and compared them with strokes during the same months a year earlier. They reviewed [...]

  • Daughter who watched mother battle MS for 20 years joins vaccine trial after own diagnosis

    A woman who watched her own mother live with the debilitating effects of multiple sclerosis (MS) for over 20 years and has now been newly diagnosed with the disease herself has said joining a new vaccine trial targeting a potential underlying cause of the condition can help treat people with relapsing MS was an “obvious [...]